These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 24890620)
1. Authors' reply to Comment on "No impact of interleukin-28B polymorphisms on spontaneous or drug-induced hepatitis delta virus clearance" [Dig. Liver Dis.2014;46:348-52]. Visco-Comandini U; Lapa D; Taibi C; Angeletti C Dig Liver Dis; 2014 Aug; 46(8):762. PubMed ID: 24890620 [No Abstract] [Full Text] [Related]
2. Comment on "No impact of interleukin-28B polymorphisms on spontaneous or drug-induced hepatitis delta virus clearance" by Ubaldo Visco-Comandini et al. [Dig. Liver Dis. 2014;46:348-52]. Keshvari M; Sharafi H; Alavian SM Dig Liver Dis; 2014 Aug; 46(8):761-2. PubMed ID: 24815081 [No Abstract] [Full Text] [Related]
3. No impact of interleukin-28B polymorphisms on spontaneous or drug-induced hepatitis delta virus clearance. Visco-Comandini U; Lapa D; Taibi C; Angeletti C; Capobianchi MR; Garbuglia AR Dig Liver Dis; 2014 Apr; 46(4):348-52. PubMed ID: 24387833 [TBL] [Abstract][Full Text] [Related]
4. Can We Predict Sustained Virologic Response to Interferon α Therapy in Patients With Chronic Hepatitis Delta Virus Infection? Scholtès C; Kumar R; Zoulim F Clin Gastroenterol Hepatol; 2015 Dec; 13(13):2350-2. PubMed ID: 26254201 [No Abstract] [Full Text] [Related]
5. Hepatitis D virus-specific cytokine responses in patients with chronic hepatitis delta before and during interferon alfa-treatment. Grabowski J; Yurdaydìn C; Zachou K; Buggisch P; Hofmann WP; Jaroszewicz J; Schlaphoff V; Manns MP; Cornberg M; Wedemeyer H; Liver Int; 2011 Oct; 31(9):1395-405. PubMed ID: 21762356 [TBL] [Abstract][Full Text] [Related]
6. Current management of delta hepatitis. Rizzetto M Liver Int; 2013 Feb; 33 Suppl 1():195-7. PubMed ID: 23286865 [TBL] [Abstract][Full Text] [Related]
7. Association Between Level of Hepatitis D Virus RNA at Week 24 of Pegylated Interferon Therapy and Outcome. Keskin O; Wedemeyer H; Tüzün A; Zachou K; Deda X; Dalekos GN; Heidrich B; Pehlivan S; Zeuzem S; Yalçın K; Gürel S; Tabak F; Idilman R; Bozkaya H; Manns M; Yurdaydin C Clin Gastroenterol Hepatol; 2015 Dec; 13(13):2342-49.e1-2. PubMed ID: 26044319 [TBL] [Abstract][Full Text] [Related]
8. Quantitative analysis of hepatitis D virus RNA and hepatitis B surface antigen serum levels in chronic delta hepatitis improves treatment monitoring. Manesis EK; Schina M; Le Gal F; Agelopoulou O; Papaioannou C; Kalligeros C; Arseniou V; Manolakopoulos S; Hadziyannis ES; Gault E; Koskinas J; Papatheodoridis G; Archimandritis AJ Antivir Ther; 2007; 12(3):381-8. PubMed ID: 17591028 [TBL] [Abstract][Full Text] [Related]
9. Resolution of chronic hepatitis delta infection after five years of peginterferon-adefovir: lessons from a case report. Brichler S; Setshedi M; Renou C Clin Res Hepatol Gastroenterol; 2013 Jun; 37(3):e81-4. PubMed ID: 23433964 [TBL] [Abstract][Full Text] [Related]
10. Letter: the potential success of long-term therapy of chronic delta hepatitis with peginterferon alfa--authors' reply. Koh C; Heller T Aliment Pharmacol Ther; 2015 Mar; 41(6):595-6. PubMed ID: 25659215 [No Abstract] [Full Text] [Related]